Ramaswamy Vivek bought ROIV
December 11, 2025 · Form 4 insider transaction
Ramaswamy Vivek bought 1,869,691 shares of Roivant Sciences Ltd. at $12.68 per share, a transaction worth $23.71M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,869,691
Price
$12.68
Total value
$23.71M
InsiderRamaswamy Vivek
Role—
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateDecember 11, 2025
Filing dateDecember 15, 2025
Shares owned after35,523,447
OwnershipDirect
10b5-1 planNo
AmendedNo